EDNRB gene variants and melanoma risk in two southern European populations

Clinical and Experimental Dermatology

Volumn 36, Issue 7, 2011, Pages 782-787

  Spica, T ^a   Fargnoli, M C ^a   Hetet, G ^b   Bertrand, G ^b   Formicone, F ^a   Descamps, V ^b   Wolkenstein, P ^c   Dupin, N ^d   Lebbe, C ^e   Basset Seguin, N ^e   Saiag, P ^f   Cambien, F ^g   Grandchamp, B ^b   Peris, K ^a   Soufir, N ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b BICHAT HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Paris Descartes University   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; EDNRB GENE; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; SOUTHERN EUROPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FRANCE; GENE FREQUENCY; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, ENDOTHELIN B; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80052966545     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04062.x     Document Type: Article

References (25)

1. Fargnoli MC, Argenziano G, Zalaudek I, Peris K,. High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Rev Anticancer Ther 2006; 6: 657-70. (Pubitemid 44192883)
2. Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006; 66: 9818-28. (Pubitemid 44672032)
3. Rees JL,. The genetics of sun sensitivity in humans. Am J Hum Genet 2004; 75: 739-51. (Pubitemid 39390484)
4. Lahav R, Ziller C, Dupin E, Le Douarin NM,. Endothelin 3 promotes neural crest cell proliferation and mediates a vast increase in melanocyte number in culture. Proc Natl Acad Sci 1996; 93: 3892-7. (Pubitemid 26144218)
5. Lahav R, Dupin E, Lecoin L, et al. Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. Proc Natl Acad Sci 1998; 95: 14214-9. (Pubitemid 28549347)
6. Levin ER,. Endothelins. N Engl J Med 1995; 333: 356-63.
7. Reid K, Turnley AM, Maxwell GD, et al. Multiple roles for endothelin in melanocyte development: regulation of progenitor number and stimulation of differentiation. Development 1996; 122: 3911-9. (Pubitemid 27033885)
8. Shin MK, Levorse JM, Ingram RS, Tilghman SM,. The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature 1999; 402: 496-501.
9. Spinella F, Rosanò L, Di Castro V, et al. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1α in human melanoma cells. Cancer Res 2007; 67: 1725-34. (Pubitemid 46383399)
10. Saldana-Caboverde A, Kos L,. Roles of endothelin signaling in melanocyte development and melanoma. Pigment Cell Melanoma Res 2010; 23: 160-70.
11. Lahav R,. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma. Int J Dev Biol 2005; 49: 173-80. (Pubitemid 40917337)
12. Tada A, Suzuki I, Im S, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 1998; 9: 575-84. (Pubitemid 28345914)
13. Demunter A, De Wolf-Peeters C, Degreef H, et al. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 2001; 438: 485-91. (Pubitemid 32449057)
14. Jamal S, Schneider RJ,. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest 2002; 110: 443-52. (Pubitemid 34919698)
15. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406: 536-40. (Pubitemid 30625740)
16. Jeffs AR, Glover AC, Slobbe LJ, et al. A gene expression signature of invasive potential in metastatic melanoma cells. PLoS ONE 2009; 4: e8461.
17. Soufir N, Meziani R, Lacapère JJ, et al. Association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst 2005; 97: 1297-301. (Pubitemid 41535370)
18. Ramensky V, Bork P, Sunyaev S,. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894-900. (Pubitemid 35012462)
19. Kanetsky PA, Ge F, Najarian D, et al. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev 2004; 13: 808-19. (Pubitemid 38737871)
20. Soufir N, Lacapere JJ, Bertrand G, et al. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma. Br J Cancer 2004; 90: 503-9. (Pubitemid 38258277)
21. Thirumaran RK, Thoelke A, Ugurel S, et al. Re: association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst 2006; 98: 1252-3. (Pubitemid 44390996)
22. Fernandez LP, Milne RL, Pita G, et al. Pigmentation-related genes and their implication in malignant melanoma susceptibility. Exp Dermatol 2009; 18: 634-42.
23. Hofstra RM, Osinga J, Buys CH,. Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype? Eur J Hum Genet 1997; 5: 180-5. (Pubitemid 27453896)
24. Fargnoli MC, Gandini S, Peris K, et al. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer 2010; 46: 1413-20.
25. Soufir N, Ollivaud L, Bertrand G, et al. A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. J Dermatol Sci 2007; 46: 61-4. (Pubitemid 46389475)